- Home
- ASND vs ENSG Comparison
ASND vs ENSG Comparison
Compare ASND & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- ENSG
- Stock Information
- Founded
- ASND 2006
- ENSG 1999
- Country
- ASND Denmark
- ENSG United States
- Employees
- ASND N/A
- ENSG N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- ENSG Hospital/Nursing Management
- Sector
- ASND Health Care
- ENSG Health Care
- Exchange
- ASND Nasdaq
- ENSG Nasdaq
- Market Cap
- ASND 10.6B
- ENSG 8.9B
- IPO Year
- ASND 2015
- ENSG 2007
- Fundamental
- Price
- ASND $198.32
- ENSG $166.17
- Analyst Decision
- ASND Strong Buy
- ENSG Buy
- Analyst Count
- ASND 16
- ENSG 7
- Target Price
- ASND $239.50
- ENSG $170.43
- AVG Volume (30 Days)
- ASND 549.0K
- ENSG 523.9K
- Earning Date
- ASND 08-07-2025
- ENSG 07-24-2025
- Dividend Yield
- ASND N/A
- ENSG 0.15%
- EPS Growth
- ASND N/A
- ENSG 41.66
- EPS
- ASND N/A
- ENSG 5.52
- Revenue
- ASND $576,332,355.00
- ENSG $4,614,838,000.00
- Revenue This Year
- ASND $79.35
- ENSG $19.45
- Revenue Next Year
- ASND $76.18
- ENSG $10.55
- P/E Ratio
- ASND N/A
- ENSG $30.11
- Revenue Growth
- ASND 54.50
- ENSG 16.31
- 52 Week Low
- ASND $111.09
- ENSG $118.73
- 52 Week High
- ASND $199.99
- ENSG $166.79
- Technical
- Relative Strength Index (RSI)
- ASND 69.11
- ENSG 75.43
- Support Level
- ASND $187.24
- ENSG $159.58
- Resistance Level
- ASND $197.67
- ENSG $166.79
- Average True Range (ATR)
- ASND 8.86
- ENSG 2.96
- MACD
- ASND 1.92
- ENSG 1.54
- Stochastic Oscillator
- ASND 95.73
- ENSG 96.76
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.